IONS·462222100·US·equity·Healthcare - Biotechnology-13D/G
IONS (IONIS PHARMACEUTICALS INC) is held by 223 institutional investors as of Q4 2025. Largest holders: Pictet Asset Management Holding SA ($107.1M), Nuveen, LLC ($48.7M), TEACHER RETIREMENT SYSTEM OF TEXAS ($39.3M). Net institutional sentiment: Mixed.
See how IONS's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer